Viemed Healthcare, Inc. Fundamental Analysis
Viemed Healthcare, Inc. (VMD) shows weak financial fundamentals with a PE ratio of 26.14, profit margin of 5.20%, and ROE of 10.66%. The company generates $0.3B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 51.0/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze VMD's fundamental strength across five key dimensions:
Efficiency Score
WeakVMD struggles to generate sufficient returns from assets.
Valuation Score
ModerateVMD shows balanced valuation metrics.
Growth Score
ModerateVMD shows steady but slowing expansion.
Financial Health Score
ExcellentVMD maintains a strong and stable balance sheet.
Profitability Score
WeakVMD struggles to sustain strong margins.
Key Financial Metrics
Is VMD Expensive or Cheap?
P/E Ratio
VMD trades at 26.14 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, VMD's PEG of 1.20 indicates fair valuation.
Price to Book
The market values Viemed Healthcare, Inc. at 2.71 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 7.21 times EBITDA. This is generally considered low.
How Well Does VMD Make Money?
Net Profit Margin
For every $100 in sales, Viemed Healthcare, Inc. keeps $5.20 as profit after all expenses.
Operating Margin
Core operations generate 8.38 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $10.66 in profit for every $100 of shareholder equity.
ROA
Viemed Healthcare, Inc. generates $7.55 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Viemed Healthcare, Inc. produces operating cash flow of $57.00M, showing steady but balanced cash generation.
Free Cash Flow
Viemed Healthcare, Inc. produces free cash flow of $25.86M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.67 in free cash annually.
FCF Yield
VMD converts 6.67% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
26.14
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
1.20
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.71
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.36
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.09
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.22
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.11
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.15
vs 25 benchmark
How VMD Stacks Against Its Sector Peers
| Metric | VMD Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 26.14 | 34.27 | Better (Cheaper) |
| ROE | 10.66% | 377.00% | Weak |
| Net Margin | 5.20% | -42945.00% (disorted) | Weak |
| Debt/Equity | 0.09 | 0.78 | Strong (Low Leverage) |
| Current Ratio | 1.22 | 5.54 | Neutral |
| ROA | 7.55% | -162.00% (disorted) | Weak |
VMD outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Viemed Healthcare, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation